TearExo Co.
Latest round
- Seed
Last raised
- Aug 2023
Total raised
- $0.3M
Investors
- 5
About TearExo Co.
, Ltd. operates as a medical equipment firm that offers cancer detection solutions. The company was founded by its CEO, Ryo Horikawa, CTO Eri Takano, CSO Akiko Ichikawa, and Toshifumi Takeuchi. TearExo offers a medical device that helps users detect cancer, mainly breast cancer, using tears, and increases the detection rate of breast cancer through cancer screening, health examinations, and thorough medical examinations with the help of ultrasonography and ultrasound J-START. The company uses Schirmer test paper to collect tears from homes, send them to a lab for testing, and after doing their study and analysis, they can find cancer without visiting hospitals.
Who invested in TearExo Co.
5 investors across 1 round
See all investors in TearExo Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 4, 2023
Amount
$0.3M
Investors
Questions about TearExo Co.
Who invested in TearExo Co.?
TearExo Co. has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TearExo Co. raised?
TearExo Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TearExo Co. last raise money?
TearExo Co.'s most recent round on record is a Seed, in Aug 2023.
What does TearExo Co. do?
TearExo Co. is a medical devices & equipment company.
Where is TearExo Co. headquartered?
TearExo Co. is headquartered in Kobe, Japan.
Which VCs invest in companies like TearExo Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at TearExo Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like TearExo Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.